Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combining nuchal translucency and serum markers in prenatal screening for Down syndrome in twin pregnancies

13 Jun 2003

Abstract excerpt

A method is described to combine the ultrasound marker nuchal translucency (NT) with serum markers so that they can be used together in prenatal screening for Down syndrome in twin pregnancies. For monochorionic twin pregnancies (taken as monozygous), the two fetus-specific NT measurements are averaged before risk is calculated and before the contribution of the serum markers is incorporated. For dichorionic twin...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Congenital Anomalies and Fetal Surgery
Share to Parvovirus B19 Infection Studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 12868090
DOI: 10.1002/pd.627

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Combining nuchal translucency and serum markers in prenatal screening for Down syndrome in twin pregnanciesPMID 12868090Read ↗

Combining Ultrasound and Biochemistry in First-Trimester Screening for Down's syndromeSemantic proximity Read ↗

First‐trimester combined ultrasound and biochemical screening for Down syndrome in routine clinical practiceSemantic proximity Read ↗

The history of the second‐trimester sonographic markers for detecting fetal Down syndrome, and their current role in obstetric practiceSemantic proximity Read ↗

First trimester fetal nuchal translucencySemantic proximity Read ↗

Screening for trisomies in dichorionic twins by measurement of fetal nuchal translucency thickness according to the mixture modelSemantic proximity Read ↗

Nuchal translucency and first trimester biochemical markers for down syndrome screening: A cost-effectiveness analysisSemantic proximity Read ↗

The impact of crown–rump length measurement error on combined Down syndrome screening: a simulation studySemantic proximity Read ↗

First and Second Trimester Antenatal Screening for Down's Syndrome: The Results of the Serum, Urine and Ultrasound Screening Study (SURUSS)Semantic proximity Read ↗

First-Trimester down syndrome screening using dried blood biochemistry and nuchal translucencySemantic proximity Read ↗

A mixture model of nuchal translucency thickness in screening for chromosomal defectsSemantic proximity Read ↗

Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestationSemantic proximity Read ↗

First-trimester screening for trisomy 21 in twin pregnancy: does the addition of biochemistry make an improvement?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.